Lixte Biotechnology Appoints New Chief Medical Officer
PremiumCompany AnnouncementsLixte Biotechnology Appoints New Chief Medical Officer
4M ago
Lixte Biotechnology appoints Jan Schellens as CMO
Premium
The Fly
Lixte Biotechnology appoints Jan Schellens as CMO
4M ago
Lixte Biotechnology provides update on recent activities
Premium
The Fly
Lixte Biotechnology provides update on recent activities
5M ago
Lixte Biotechnology announces presentation of LB-100
PremiumThe FlyLixte Biotechnology announces presentation of LB-100
7M ago
Lixte Biotechnology enters patent license agreement with NINDS, NCI
Premium
The Fly
Lixte Biotechnology enters patent license agreement with NINDS, NCI
7M ago
Lixte Biotechnology announces first patient dosed in Phase 1b/2 trial of LB-100
Premium
The Fly
Lixte Biotechnology announces first patient dosed in Phase 1b/2 trial of LB-100
8M ago
Lixte Biotechnology announces supported collaborative trial to study LB-100
PremiumThe FlyLixte Biotechnology announces supported collaborative trial to study LB-100
1y ago
Lixte Biotechnology files to sell 583,334 shares of common stock for holders
Premium
The Fly
Lixte Biotechnology files to sell 583,334 shares of common stock for holders
1y ago
Lixte Biotechnology to sell 583,334 shares at $6.00 in registered direct offerin
Premium
The Fly
Lixte Biotechnology to sell 583,334 shares at $6.00 in registered direct offerin
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100